Is myeloperoxidase a key component in the ROS-induced vascular damage related to Nephropathy in type 2 diabetes?

Antioxidants and Redox Signaling

Volumn 19, Issue 13, 2013, Pages 1452-1458

  Rovira Llopis, Susana ^a   Rocha, Milagros ^a,b   Falcon, Rosa ^a   De Pablo, Carmen ^b   Alvarez, Angeles ^b   Jover, Ana ^a   Hernandez Mijares, Antonio ^a,b   Victor, Victor M ^a,b  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR; ANTIHYPERTENSIVE AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRIC ACID DERIVATIVE; GLITAZONE DERIVATIVE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE; SULFONYLUREA; TUMOR NECROSIS FACTOR ALPHA; CELL ADHESION MOLECULE; CYTOKINE; PEROXIDASE;

ADULT; BLOOD VESSEL INJURY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; ENDOTHELIUM; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; INSULIN TREATMENT; LEUKOCYTE; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; MAJOR CLINICAL STUDY; NEUTROPHIL; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; CELL ADHESION; CELL CULTURE; CYTOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; UMBILICAL VEIN ENDOTHELIAL CELL;

CELL ADHESION; CELL ADHESION MOLECULES; CELLS, CULTURED; CYTOKINES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LEUKOCYTES; MIDDLE AGED; PEROXIDASE; REACTIVE OXYGEN SPECIES;

EID: 84886289342     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5307     Document Type: Review

References (9)

1. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001.
2. Haraldsson B, Nystrom J, and Deen WM. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev 88: 451-487, 2008.
3. Hernandez-Mijares A, Rocha M, Apostolova N, Borras C, Jover A, Bañ uls C, Sola E, and Victor VM. Mitochondrial complex I impairment in leukocytes from type 2 diabetic patients. Free Radic Biol Med 50: 1215-1221, 2011.
4. Hernandez-Mijares A, Rocha M, Rovira-Llopis S, Bañ uls C, Bellod L, de Pablo C, Alvarez A, Roldan-Rorres I, Sola-Izquierdo E, and Victor VM. Human leukocyte/endothelial cell interactions and mitochondrial dysfunction in type 2 diabetic patients and their association with silent myocardial ischemia. Diabetes Care 2013 [Epub ahead of print]; DOI: 10.2337/dc12-1224.
5. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, and Munzel T. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88: E14-E22, 2001.
6. Sato N, Kashima K, Tanaka Y, Shimizu H, and Mori M. Effect of granulocyte-colony stimulating factor on generation of oxygen-derived free radicals and myeloperoxidase activity in neutrophils from poorly controlled NIDDM patients. Diabetes 46: 133-137, 1997.
7. Victor VM, Rocha M, Bañ uls C, Alvarez A, de Pablo C, Sanchez-Serrano M, Gomez M, and Hernandez-Mijares A. Induction of oxidative stress and human leukocyte/endothelial cell interactions in polycystic ovary syndrome patients with insulin resistance. J Clin Endocrinol Metab 96: 3115-3122, 2011.
8. Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, and Tataranni PA. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51: 455-461, 2002.
9. Zhang C, Yang J, and Jennings LK. Leukocyte-derived myeloperoxidase amplifies high-glucose-induced endothelial dysfunction through interaction with high-glucose-stimulated, vascular non-leukocyte-derived reactive oxygen species. Diabetes 53: 2950-2959, 2004.